🇺🇸 FDA
Pipeline program

Armodafinil 150 mg/day

C10953/2036/ON/US

Phase 2 small_molecule terminated

Quick answer

Armodafinil 150 mg/day for Fatigue is a Phase 2 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Fatigue
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials